Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

305 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PD-L1 blockade in combination with carboplatin as immune induction in metastatic lobular breast cancer: the GELATO trial.
Voorwerk L, Isaeva OI, Horlings HM, Balduzzi S, Chelushkin M, Bakker NAM, Champanhet E, Garner H, Sikorska K, Loo CE, Kemper I, Mandjes IAM, de Maaker M, van Geel JJL, Boers J, de Boer M, Salgado R, van Dongen MGJ, Sonke GS, de Visser KE, Schumacher TN, Blank CU, Wessels LFA, Jager A, Tjan-Heijnen VCG, Schröder CP, Linn SC, Kok M. Voorwerk L, et al. Among authors: schumacher tn. Nat Cancer. 2023 Apr;4(4):535-549. doi: 10.1038/s43018-023-00542-x. Epub 2023 Apr 10. Nat Cancer. 2023. PMID: 37038006 Free PMC article. Clinical Trial.
Tracing and characterization of the low-avidity self-specific T cell repertoire.
de Visser KE, Cordaro TA, Kioussis D, Haanen JB, Schumacher TN, Kruisbeek AM. de Visser KE, et al. Among authors: schumacher tn. Eur J Immunol. 2000 May;30(5):1458-68. doi: 10.1002/(SICI)1521-4141(200005)30:5<1458::AID-IMMU1458>3.0.CO;2-2. Eur J Immunol. 2000. PMID: 10820394 Free article.
Circumventing T-cell tolerance to tumour antigens.
Kessels HW, de Visser KE, Kruisbeek AM, Schumacher TN. Kessels HW, et al. Among authors: schumacher tn. Biologicals. 2001 Sep-Dec;29(3-4):277-83. doi: 10.1006/biol.2001.0300. Biologicals. 2001. PMID: 11851328
CD8+ T cell tolerance and cancer immunotherapy.
De Visser KE, Schumacher TN, Kruisbeek AM. De Visser KE, et al. Among authors: schumacher tn. J Immunother. 2003 Jan-Feb;26(1):1-11. doi: 10.1097/00002371-200301000-00001. J Immunother. 2003. PMID: 12514424 Review.
Combination of targeted therapy and immunotherapy in melanoma.
Blank CU, Hooijkaas AI, Haanen JB, Schumacher TN. Blank CU, et al. Among authors: schumacher tn. Cancer Immunol Immunother. 2011 Oct;60(10):1359-71. doi: 10.1007/s00262-011-1079-2. Epub 2011 Aug 17. Cancer Immunol Immunother. 2011. PMID: 21847631 Free PMC article. Review.
305 results